| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |